Why eliminating the X-waiver for prescribing buprenorphine is just one step toward recovery for patients, and what can be done to help bridge the gap.

A Health Affairs article covers recent activity and policy changes around prescribing buprenorphine, a medication for treating opioid use disorder (OUD). As barriers for prescribing buprenorphine were lowered in April 2021, the authors discuss additional work that is underway, in order to expand access to treatment, and more.

Read more